fig3
![LDL apheresis or PCSK9 inhibition? Sometimes we have to combine them](https://image.oaes.cc/33d6a8ff-5c30-4f72-8bc9-3deec42fb034/1998.fig.3.png)
Figure 3. LDL-C levels during the various treatment strategies. The oral treatment was continued during treatment with PCSK9 and LDL apheresis. LDL-C: low density lipoprotein cholesterol; PCSK9: proprotein convertase subtilisin/kexin type 9
Figure 3. LDL-C levels during the various treatment strategies. The oral treatment was continued during treatment with PCSK9 and LDL apheresis. LDL-C: low density lipoprotein cholesterol; PCSK9: proprotein convertase subtilisin/kexin type 9
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/